|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
REMDESIVIR |
J05AB16 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005622 |
03-07-2020 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
BEVACIZUMAB |
S01LA08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
SPARSENTAN |
C09XX01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
MARIBAVIR |
J05AX10 |
DE
|
I
|
14-11-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
ETRASIMOD |
L04AE05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
DANTROLENE |
M03CA01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006009 |
29-05-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
DOPAMINE |
C01CA04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
